Hartford Investment Management Co. Raises Position in Thermo Fisher Scientific Inc. (TMO)
Hartford Investment Management Co. increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 87,724 shares of the medical research company’s stock after acquiring an additional 2,568 shares during the period. Hartford Investment Management Co.’s holdings in Thermo Fisher Scientific were worth $16,597,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Chicago Partners Investment Group LLC bought a new stake in Thermo Fisher Scientific during the 2nd quarter worth approximately $108,000. Shine Investment Advisory Services Inc. bought a new stake in Thermo Fisher Scientific during the 2nd quarter worth approximately $113,000. Ropes Wealth Advisors LLC increased its holdings in Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after purchasing an additional 97 shares in the last quarter. Atlantic Trust LLC bought a new stake in Thermo Fisher Scientific during the 2nd quarter worth approximately $138,000. Finally, Grove Bank & Trust increased its holdings in Thermo Fisher Scientific by 19.9% during the 2nd quarter. Grove Bank & Trust now owns 860 shares of the medical research company’s stock worth $150,000 after purchasing an additional 143 shares in the last quarter. 86.16% of the stock is currently owned by hedge funds and other institutional investors.
In other news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the transaction, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.49% of the company’s stock.
A number of analysts have commented on the company. Jefferies Group reissued a “hold” rating and set a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Goldman Sachs Group started coverage on Thermo Fisher Scientific in a report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 target price for the company. Barclays reaffirmed an “overweight” rating and issued a $215.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Argus reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Leerink Swann increased their price objective on Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a report on Monday, October 9th. One research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $205.21.
Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $3.95 during mid-day trading on Friday, hitting $192.27. The company had a trading volume of 3,851,238 shares, compared to its average volume of 1,689,932. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a one year low of $139.88 and a one year high of $201.20. The stock has a market capitalization of $75,515.45, a P/E ratio of 20.69, a PEG ratio of 1.73 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the business posted $2.03 earnings per share. The firm’s revenue was up 13.9% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. Thermo Fisher Scientific’s payout ratio is 10.19%.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Daily Political and is the property of of Daily Political. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/12/16/hartford-investment-management-co-raises-position-in-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.